You are here: Industry Insights > vaccine

News List

Neutralizing antibodies protect against severe COVID-19 worldpharmanews
December 21, 2020
Understanding the body's immune response to SARS-CoV-2, the virus that causes COVID-19, is key to developing effective treatments and long-lasting vaccines.
India to make 300 million Sputnik V vaccines expresspharma
December 21, 2020
India will produce about 300 million doses of Russia’s Sputnik V coronavirus vaccines next year, a Russian official was quoted as saying, nearly three times the previously known number as deals have been signed with more manufacturers.
Oxford/AstraZeneca vaccine likely to get approval by year-end in UK expresspharma
December 21, 2020
AstraZeneca has said a further 15 million doses of active ingredients are ready and can be filled into vials in a matter of days.
US CDC gives recommendations for COVID-19 inoculation after allergic reactions expresspharma
December 21, 2020
People who have had a severe allergic reaction to any ingredient in a COVID-19 vaccine should avoid the vaccine formulation containing the ingredient, CDC said.
Codagenix Completes Dosing for Trial of Live-Attenuated, Intranasal Vaccine for RSV americanpharmaceuticalreview
December 18, 2020
Codagenix announced the completion of dosing in a Phase 1 clinical trial of its live attenuated CodaVax™-RSV vaccine, an intranasally-administered vaccine for the prevention of respiratory syncytial virus (RSV).
Many people may not receive a COVID-19 vaccine until 2022 europeanpharmaceuticalreview
December 17, 2020
Studies show that more than a fifth of the global population, mostly in low- and middle-income countries, may have to wait until at least 2022 to receive a COVID-19 vaccine.
Vaccine demonstrates efficacy against mutated polio strain in Phase II study europeanpharmaceuticalreview
December 15, 2020
A clinical trial has shown that nOPV2 has the potential to overcome outbreaks caused by a mutated polio strain linked to the Sabin vaccine.
Rich countries buy up majority of COVID-19 vaccine doses, People’s Vaccine Alliance says europeanpharmaceuticalreview
December 11, 2020
According to the alliance, 70 poor countries will only be able to vaccinate one in 10 people against COVID-19 next year after rich countries bought up most prophylactics.
A large basket of COVID-19 vaccine candidates is important: Renu Swarup expresspharma
December 07, 2020
She said the vaccines that are being developed indigenously are on different platforms and each has its own benefits and challenges.
KU Leuven vaccine candidate protects against COVID-19 and yellow fever worldpharmanews
December 04, 2020
Virologists at the Rega Institute at KU Leuven (Belgium) have developed a vaccine candidate against COVID-19 based on the yellow fever vaccine, which as a result also works against yellow fever.

Previous page 1 2 3 4 5 6 7 8 9 10 ... 100 101 Next page